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Abstract 
Background: Moyamoya disease (MMD) is a rare condition, where the most 
appropriate treatment for it is yet to be determined. Surgery remains an 
important method of choice although it is considered a form of palliative care. 
The outcome following surgery is very difficult to judge, and there is no 
standardised measurement to assess it. It is therefore important to know 
which approach for such patient is adequate. 
 
Clinical Presentation: A 21-year-old male patient presented with signs and 
symptoms of intracranial haemorrhage. Upon investigation, a diagnosis of 
bilateral MMD was made, and one-sided direct bypass surgery was 
subsequently performed. At 3-year follow-up, there is no evidence of recurrent 
cerebral vascular event. 
 
Conclusion: This case provided further evidence that direct bypass surgery is 
beneficial for patient in terms of blood flow improvement and symptom relieve. 
Although there is no consensus on whether bilateral surgical intervention is 
mandatory for patient with bilateral MMD, unilateral bypass might be sufficient 
enough. Further study is required to evaluate the best approach for such group 
of patient.  
Introduction 
Moyamoya disease (MMD) was first reported in 1957 by Shimizu and colleagues as 
hypoplasia of the bilateral internal carotid arteries (ICAs). Moyamoya syndrome has 
been used to describe a similar condition when an underlying pathology, such as 
atherosclerosis, radiation therapy or sickle cell disease, can be identified. The 
syndrome consists of unilateral or bilateral steno-occlusive arterial changes and 
associated Moyamoya collaterals 1. The incidence of MMD peaks in two age groups: 
children who are approximately 5 years of age and adults in their mid-40s 2. Chances 
of having MMD are 2-folded higher in female than male 2. Three types of research have 
been conducted to explain the pathogenesis of MMD: pathological analysis of affected 
tissue, genetic-linkage studies and studies of the role of angiogenesis and extracellular 
matrix–related peptides in disease development and progression. Pathological 
analysis has revealed that vessel occlusion is not due to arteriosclerotic or 
inflammatory, but is a result of smooth-muscle cell hyperplasia and luminal 
thrombosis 3. Suzuki and Takaku described six separate angiographic stages of 
Moyamoya based on the pattern of steno-occlusion and collateral formation.4 Grade I 
refers to the narrowing of the ICA apex without Moyamoya collaterals. Grade II refers 
to ICA stenosis along with initiation of Moyamoya collaterals. Grade III refers to 
progression of the ICA stenosis with intensification of Moyamoya collaterals. Grade IV 
refers to development of external carotid artery (ECA) collaterals. Grade V refers to 
intensification of ECA collaterals along with a reduction of Moyamoya collaterals. 
Grade VI represents the final stage of the disease process with total occlusion of the 
ICA and disappearance of Moyamoya collaterals 4. The pathogenesis of MMD is 
irreversible despite treatment. Current available treatments are aiming to prevent 
stroke by improving cerebral blood flow (CBF) to the affected cerebral hemisphere. 
Medical therapy has been used in patients with MMD, particularly in mild cases or 
where surgical intervention is contraindicated. But there is few data showing either its 
short-term or long-term efficacy. Surgical treatment for patients with MMD typically 
uses the ECA as a source of new blood supply to the ischaemic hemisphere. There are 
two types of revascularisation: direct and indirect. In direct revascularisation, a branch 
of the ECA is directly anastomosed to a cortical artery. In indirect revascularisation, the 
ECA in direct contact with the brain, leading to an ingrowth of new blood vessels to 
the underlying cerebral cortex 3.  
Case report 
A 21-year-old male presented with a history of repeated headache accompanied by 
vomiting for 5 days. His memory and learning ability are worse than his peers. His past 
history and family history are unremarkable. On examination, he was afebrile and 
conscious There is no papilledema or other neurological deficit. Computed 
tomography (CT) of the head showed bilateral intraventricular haemorrhage. 
Diagnostic digital subtraction angiography (DSA) confirmed stenosis at the bifurcation 
of right ICA and anterior cerebral artery with collateral vessels (Figure 1) . The left ICA 
and the anterior cerebral artery are partially occluded with collateral vessel formation 
(Figure 1). CT angiography (CTA) of the head was also performed with similar findings 
as the DSA (Figure 2). CT perfusion (CTP) of the head revealed a hypovolemic left 
cerebral hemisphere comparing to the right (Figure 2). 
 
The diagnosis of bilateral MMD was established based on the above evidence, with a 
more severe imagine findings on the left. Diameters of the following arteries are 
measured by vascular ultrasonography, anterior branch of left superficial temporal 
artery (STA) (1.4mm), posterior branch of STA (2.0mm). The anterior branch of the 
right STA is missing and posterior branch of STA (1.5mm). The reasonable vascular 
diameters improved the chances of success anastomosis. Since the lesion on the left 
side is more severe than on the right side (Figure 1 and 2). A decision to perform a 
unilateral bypass surgery on the left side was made. The procedure of STA to middle 
cerebral artery (MCA) bypass was carried out giving its clinical outcomes, particularly 
in diminishing the incidence of recurrent ischaemic events. The patient underwent an 
uneventfully operation with no postoperative complications. The patient was fit to be 
discharged on the 14th post-operative day. CTA 2 weeks post-operatively showed 
patent vascular anastomosis with newborn compensatory proliferated vasculature 
leading to improved CBF as demonstrated by the CTP (Figure 2). One month post-
operative DSA also demonstrated anastomosis patency (Figure 1). At 3-year follow-up, 
there is no evidence of intracranial haemorrhage or other complication. Unfortunately, 
no more image follow-up is feasible after one month since the patient is from a distant 
rural area.  
Discussion 
We presented a unilateral surgical intervention for a 21-year-old male with bilateral 
symptomatic MMD by STA-MCA bypass. The direct approach by STA-MCA bypass is a 
reliable treatment for MMD, which can immediately improve symptoms and reduce 
recurrent ischaemic events. Therefore it is the procedure of choice for this patient. 
Although a favourable clinical outcome is observed in this case, this may not 
necessarily match the improvement in the haemodynamic parameters. In addition, 
although no evidence of long-term complication, whether this is a result of the 
revascularisation is unknown. Especially when there is no long-term DSA data available 
in this case. 
 
The STA-MCA procedure is technically demanding and can be associated with 
devastating haemorrhage. Usually, direct bypass is limited to adults or elder children 
due to the small caliber of the STA. Indirect bypass can also be considered in patients 
with serious medical comorbidities or in patients with inadequate recipient or donor 
artery grafts. Encephalomyosynangiosis, for example, is a safe and easy procedure, 
which can be offered in these groups of patients. However, this approach also has its 
disadvantages. Firstly, it requires larger craniotomy with dura opening. Secondly, it is 
associated with significant postoperative complications such as seizures and/or mass 
effect on the brain. Thirdly, it requires longer time to establish collateral vessel 
formation 5. 
 
In recent years, surgical revascularisation is recommended in most symptomatic cases 
to reduce ischemic symptoms and to improve hemodynamic status 6. Direct 
revascularisation in particular, provides significant improvement in this scenario 7. 
However, the effect on CBF after revascularisation remains controversial. In one study, 
short-term follow up after 3-6 months showed decreased CBF after direct 
revascularisation at the ipsilateral symptomatic hemisphere 7. In other study,  total 
CBF improvement can be achieved after STA–MCA bypass in symptomatic patients 8. 
Evidence also showed that unilateral revascularisation could increase CBF in the 
contralateral non-intervened hemisphere 9. In one study, Chen et al demonstrated 
significantly improved CBF in less than 2 weeks after operation 10. CTP was used to in 
this study to provide a quantitative analysis of CBF before and after STA-MCA 
anastomosis 10. 
 
The most appropriate revascularisation procedure for patients with MMD is not yet 
well defined. Nonetheless, ample evidence suggests that surgical intervention 
improves the outcome of patients with symptomatic MMD. Each procedure has its 
own advantages and disadvantages. Direct revascularisation may lead to immediate 
improvement of symptoms and could decrease recurrent ischaemic events. Although 
technically demanding and the possibility of life-threatening haemorrhage, direct 
bypass remains the preferred procedure for patients with symptomatic MMD. 
Previously, researchers have not used standardised outcome measures to assess 
patients on presentation and on long-term follow-up. It is suggested that 
neuropsychological testing after surgical intervention is critical to accurately assess 
outcomes 11. Therefore, it should be integrated into future clinical trials. Direct and 
indirect revascularisation will continue to play a major role in the treatment of MMD. 
The choice of procedure appears to depend on the surgeon’s experience and on the 
nature of the patient’s presentation. Randomised prospective clinical trials comparing 
the various procedures may be developed to define the most appropriate indications 
in different patient groups. Although beneficial presentation is evident in our patient 
after the unilateral STA-MCA bypass, no solid conclusion can be drawn from a single 
case. However, this paper opened an argument and also added one piece of evidence 
that unilateral direct bypass might be sufficient for patient with bilateral MMD. 
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Figure 1. Digital subtraction angiography (DSA): pre-operative DSA showed (A-B) 
stenosis at the bifurcation of right ICA and anterior cerebral artery with collateral 
vessels, (A) Towne’s view, (B) lateral view. Pre-operative DSA showered (C-D) partially 
occluded left ICA and anterior cerebral artery with collateral vessel formation, (C) 
Towne’s view, (D) lateral view. One month post-operative DSA showed development of 
leptomeningeal anastomosis on the left side (E, lateral view) and right side (F, lateral 
view). 
 
 
 
 
 
   
Figure 2. Computed tomography angiography (CTA) and CT perfusion (CTP): (A) pre-
operative CTA. (B) two weeks post-operatiive CTA showed newborn compensatory 
proliferated vasculature. (C) preoperative CTP. (D) two weeks post-operative CTP 
showed increased cerebral blood flow. 
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